Search - tctmd.com

Displaying 481 - 500 of 1993

Sort: Relevancy | Date

Presentation TCT 2022

JenaValve Trilogy TAVR System for the Treatment of Aortic Regurgitation: Real-World Results From a Multicenter Cohort

Presenter: Alexander R. Tamm

September 18, 2022

Presentation TCT 2022

ShortCut: First Dedicated Transcatheter Leaflet Splitting Device (PiCardia)

Presenter: Susheel K. Kodali

September 18, 2022

Presentation TCT 2022

The CELT ACD® Large Bore (18F) Arterial Closure Device (Vasorum)

Presenter: Jim E. Coleman

September 18, 2022

News Conference News TCT 2022

Sizing Mismatch a Problem for Balloon-Expandable Valves in Small Annuli TAVI

Yael L. Maxwell

September 18, 2022

Presentation TCT 2022

Tips and Tricks with Workhorse TAVR Devices

Presenter: Raj Makkar

September 18, 2022

Presentation TCT 2022

Central Wrapping Concept for TMVR (Innovalve): Device Description and Early Clinical Results

Presenter: Chet Rihal

September 18, 2022

Presentation TCT 2022

TCT 664: Emerging technique for coronary protection in Valve in Valve TAVR : The Shortcut Device

Presenter: Benjamin Séguy

September 18, 2022

News Conference News TCT 2022

Amulet, Watchman 2.5 LAAO Devices Provide Comparable 3-Year Outcomes

Todd Neale

September 18, 2022

Presentation TCT 2022

Chordal Replacement and Annuloplasty in One Device With a Leaflet-Independent Procedure for DMR (Vesalius)

Presenter: Peter Skarsgard

September 18, 2022

News Conference News TCT 2022

As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant

Michael O'Riordan

September 18, 2022

Presentation TCT 2022

TCT 386: A Comparative Meta-Analysis of Newer Percutaneous Left Atrial Appendage Occlusion Devices

Presenter: Gauravpal Singh Gill

September 18, 2022

Presentation TCT 2022

Current FDA-Approved Devices: How to Select; Lesion-Specific Differences

Presenter: Reda Ibrahim

September 18, 2022

News Conference News TCT 2022

To Cure What Ails US Healthcare: Creativity, Value, Fairness, Says FDA’s Califf

L.A. McKeown

September 18, 2022

Presentation TCT 2022

TCT 383: Effect of Adding a Novel Coating to the Next-Generation Watchman Device in a Challenging Experimental Animal Model

Presenter: Walid Saliba

September 18, 2022

Presentation TCT 2022

Ongoing Clinical Trials and the Future of LAAC

Presenter: Matthew Price

September 18, 2022

Presentation TCT 2022

TCT 380: Predicting Device Related Thrombosis Using Computational Fluid Dynamics

Presenter: Brennan Vogl

September 18, 2022

Presentation TCT 2022

Recent Clinical Trials & Registries: Update 2022

Presenter: Kolja Sievert

September 18, 2022

Presentation TCT 2022

OpSens SavvyWire: Device Review & Case Example

Presenter: Philippe Genereux

September 18, 2022

Presentation TCT 2022

Excluding the Infarcted LV Apical Segment of the Heart: The Bioventrix Device and Pivotal Study

Presenter: Rishi Puri

September 18, 2022

News Conference News TCT 2022

FLASH: More Data to Support Mechanical Thrombectomy in PE

L.A. McKeown

September 18, 2022

Advertisement

JenaValve Trilogy TAVR System for the Treatment of Aortic Regurgitation: Real-World Results From a Multicenter Cohort

ShortCut: First Dedicated Transcatheter Leaflet Splitting Device (PiCardia)

The CELT ACD® Large Bore (18F) Arterial Closure Device (Vasorum)

Sizing Mismatch a Problem for Balloon-Expandable Valves in Small Annuli TAVI

Tips and Tricks with Workhorse TAVR Devices

Central Wrapping Concept for TMVR (Innovalve): Device Description and Early Clinical Results

TCT 664: Emerging technique for coronary protection in Valve in Valve TAVR : The Shortcut Device

Amulet, Watchman 2.5 LAAO Devices Provide Comparable 3-Year Outcomes

Chordal Replacement and Annuloplasty in One Device With a Leaflet-Independent Procedure for DMR (Vesalius)

As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant

TCT 386: A Comparative Meta-Analysis of Newer Percutaneous Left Atrial Appendage Occlusion Devices

Current FDA-Approved Devices: How to Select; Lesion-Specific Differences

To Cure What Ails US Healthcare: Creativity, Value, Fairness, Says FDA’s Califf

TCT 383: Effect of Adding a Novel Coating to the Next-Generation Watchman Device in a Challenging Experimental Animal Model

Ongoing Clinical Trials and the Future of LAAC

TCT 380: Predicting Device Related Thrombosis Using Computational Fluid Dynamics

Recent Clinical Trials & Registries: Update 2022

OpSens SavvyWire: Device Review & Case Example

Excluding the Infarcted LV Apical Segment of the Heart: The Bioventrix Device and Pivotal Study

FLASH: More Data to Support Mechanical Thrombectomy in PE

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content